Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 23060 matches for

Novartis receives European licence for Aimovig® (erenumab), the first treatment designed specifically for the prevention of migraine

Human pain nerves grown in the lab that can release CGRP and be used to identify new migraine treatments

Newsletter Sign-up

Neurometrology Group newsletter sign-up

Reporting a problem

Online induction completion

Similar stories

Alan Davidson Foundation renews funding for ground-breaking motor neuron disease research at Oxford

As part of its renewed commitment, the Alan Davidson Foundation will continue to fund a full-time project manager to facilitate the ongoing coordination and growth of the ACORN study. The foundation is also contributing to the cost of a research fellow to support the next phase of the project.

First author publication for final year medical student on Parkinson’s Disease review

Simon Rinaldi awarded an MRC Senior Clinical Fellowship

Study highlights effectiveness of neuromodulatory therapy on severe epileptic focal seizures

Vice-Chancellor's Awards for Teaching, Research Culture and Engagement for NDCN teams

New paper explores how the immune system fails in CASPR2-antibody encephalitis